18 May 2026
Non-Adherence to Anti-Tuberculosis Treatment and Its Determinants Among Tuberculosis Patients in TanzaniaPublisher siteJournal of Community Health, Tuberculosis Research and Epidemiology
Active, last published 2026
In hemoglobinopathies and related disorders
Indo
Ndaigeze
Scholar“Research focused on Hemoglobinopathies and Related Disorders and adjacent fields.”
Hubert Kairuki University
Tanzania
Claim Your ProfileTanzania0
H-index
0
Citations
Indo has not officially claimed their profile. If you are Indo, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ndo Ndaigeze is a researcher working on Hemoglobinopathies and Related Disorders. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Indo's work has been cited 0 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Hemoglobinopathies and Related Disorders×2
04 · Where I am
Affiliations
Affiliation on published researchHubert Kairuki Memorial University, TanzaniaDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works6 Aug 2025
Determinants of perception and willingness to uptake premarital screening test for sickle cell disease among health sciences undergraduate students in Dar es Salaam, TanzaniaPublisher siteJournal of Community Genetics, Hemoglobinopathies and Related Disorders
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Indo?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you